nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—migraine—Prednisone—multiple sclerosis	0.507	1	CpDpCtD
Eletriptan—CYP2A6—Prednisolone—multiple sclerosis	0.0344	0.132	CbGbCtD
Eletriptan—CYP2D6—Fingolimod—multiple sclerosis	0.0261	0.1	CbGbCtD
Eletriptan—CYP2A6—Dexamethasone—multiple sclerosis	0.0203	0.0777	CbGbCtD
Eletriptan—ABCB1—Methylprednisolone—multiple sclerosis	0.0179	0.0686	CbGbCtD
Eletriptan—CYP3A4—Fingolimod—multiple sclerosis	0.0166	0.0638	CbGbCtD
Eletriptan—HTR1B—trigeminal nucleus—multiple sclerosis	0.015	0.189	CbGeAlD
Eletriptan—HTR1D—trigeminal nucleus—multiple sclerosis	0.0145	0.183	CbGeAlD
Eletriptan—CYP2C19—Prednisone—multiple sclerosis	0.0134	0.0515	CbGbCtD
Eletriptan—ABCB1—Mitoxantrone—multiple sclerosis	0.013	0.05	CbGbCtD
Eletriptan—ABCB1—Betamethasone—multiple sclerosis	0.0116	0.0446	CbGbCtD
Eletriptan—ABCB1—Prednisolone—multiple sclerosis	0.0115	0.044	CbGbCtD
Eletriptan—ABCB1—Prednisone—multiple sclerosis	0.0108	0.0416	CbGbCtD
Eletriptan—CYP3A4—Methylprednisolone—multiple sclerosis	0.0107	0.0411	CbGbCtD
Eletriptan—HTR1D—meninx—multiple sclerosis	0.00965	0.122	CbGeAlD
Eletriptan—HTR1F—trigeminal nerve—multiple sclerosis	0.00962	0.121	CbGeAlD
Eletriptan—CYP2C19—Dexamethasone—multiple sclerosis	0.00838	0.0322	CbGbCtD
Eletriptan—CYP3A4—Triamcinolone—multiple sclerosis	0.00811	0.0312	CbGbCtD
Eletriptan—CYP3A4—Mitoxantrone—multiple sclerosis	0.00781	0.03	CbGbCtD
Eletriptan—CYP2C9—Dexamethasone—multiple sclerosis	0.00696	0.0267	CbGbCtD
Eletriptan—CYP3A4—Betamethasone—multiple sclerosis	0.00696	0.0267	CbGbCtD
Eletriptan—CYP3A4—Prednisolone—multiple sclerosis	0.00687	0.0264	CbGbCtD
Eletriptan—ABCB1—Dexamethasone—multiple sclerosis	0.00676	0.0259	CbGbCtD
Eletriptan—CYP3A4—Prednisone—multiple sclerosis	0.00649	0.0249	CbGbCtD
Eletriptan—CYP2D6—Dexamethasone—multiple sclerosis	0.00637	0.0244	CbGbCtD
Eletriptan—ABCB1—Methotrexate—multiple sclerosis	0.00543	0.0209	CbGbCtD
Eletriptan—CYP3A4—Dexamethasone—multiple sclerosis	0.00405	0.0155	CbGbCtD
Eletriptan—HTR1B—trigeminal nerve—multiple sclerosis	0.00394	0.0498	CbGeAlD
Eletriptan—HTR1D—trigeminal nerve—multiple sclerosis	0.00382	0.0482	CbGeAlD
Eletriptan—HTR7—pons—multiple sclerosis	0.00214	0.027	CbGeAlD
Eletriptan—HTR7—peripheral nervous system—multiple sclerosis	0.00142	0.018	CbGeAlD
Eletriptan—HTR1E—brainstem—multiple sclerosis	0.00131	0.0165	CbGeAlD
Eletriptan—HTR7—nerve—multiple sclerosis	0.00111	0.014	CbGeAlD
Eletriptan—HTR1F—nervous system—multiple sclerosis	0.00079	0.00997	CbGeAlD
Eletriptan—HTR1F—central nervous system—multiple sclerosis	0.000761	0.0096	CbGeAlD
Eletriptan—HTR1E—nervous system—multiple sclerosis	0.000685	0.00864	CbGeAlD
Eletriptan—HTR1E—central nervous system—multiple sclerosis	0.000659	0.00832	CbGeAlD
Eletriptan—HTR1B—brainstem—multiple sclerosis	0.000618	0.0078	CbGeAlD
Eletriptan—HTR1F—brain—multiple sclerosis	0.000604	0.00762	CbGeAlD
Eletriptan—HTR1D—brainstem—multiple sclerosis	0.000598	0.00755	CbGeAlD
Eletriptan—HTR1E—brain—multiple sclerosis	0.000523	0.0066	CbGeAlD
Eletriptan—HTR1A—brainstem—multiple sclerosis	0.000499	0.00629	CbGeAlD
Eletriptan—HTR7—brainstem—multiple sclerosis	0.000477	0.00602	CbGeAlD
Eletriptan—HTR1B—midbrain—multiple sclerosis	0.000394	0.00497	CbGeAlD
Eletriptan—HTR1B—spinal cord—multiple sclerosis	0.000384	0.00485	CbGeAlD
Eletriptan—HTR1D—midbrain—multiple sclerosis	0.000381	0.00481	CbGeAlD
Eletriptan—CYP2A6—cerebellum—multiple sclerosis	0.000357	0.0045	CbGeAlD
Eletriptan—HTR7—medulla oblongata—multiple sclerosis	0.000332	0.00419	CbGeAlD
Eletriptan—HTR1B—nervous system—multiple sclerosis	0.000324	0.00409	CbGeAlD
Eletriptan—HTR1A—midbrain—multiple sclerosis	0.000318	0.00401	CbGeAlD
Eletriptan—HTR1D—nervous system—multiple sclerosis	0.000313	0.00396	CbGeAlD
Eletriptan—HTR1B—central nervous system—multiple sclerosis	0.000312	0.00393	CbGeAlD
Eletriptan—HTR1A—spinal cord—multiple sclerosis	0.00031	0.00391	CbGeAlD
Eletriptan—HTR7—midbrain—multiple sclerosis	0.000304	0.00383	CbGeAlD
Eletriptan—HTR1D—central nervous system—multiple sclerosis	0.000302	0.00381	CbGeAlD
Eletriptan—HTR7—spinal cord—multiple sclerosis	0.000296	0.00374	CbGeAlD
Eletriptan—HTR2B—nervous system—multiple sclerosis	0.000292	0.00368	CbGeAlD
Eletriptan—CYP2A6—brain—multiple sclerosis	0.00029	0.00366	CbGeAlD
Eletriptan—HTR2B—central nervous system—multiple sclerosis	0.000281	0.00354	CbGeAlD
Eletriptan—CYP2D6—brainstem—multiple sclerosis	0.000271	0.00342	CbGeAlD
Eletriptan—HTR1A—nervous system—multiple sclerosis	0.000261	0.0033	CbGeAlD
Eletriptan—HTR1A—central nervous system—multiple sclerosis	0.000252	0.00317	CbGeAlD
Eletriptan—HTR7—nervous system—multiple sclerosis	0.00025	0.00315	CbGeAlD
Eletriptan—HTR1B—brain—multiple sclerosis	0.000247	0.00312	CbGeAlD
Eletriptan—HTR1A—cerebellum—multiple sclerosis	0.000246	0.0031	CbGeAlD
Eletriptan—HTR7—central nervous system—multiple sclerosis	0.00024	0.00303	CbGeAlD
Eletriptan—HTR1D—brain—multiple sclerosis	0.00024	0.00302	CbGeAlD
Eletriptan—HTR7—cerebellum—multiple sclerosis	0.000235	0.00297	CbGeAlD
Eletriptan—HTR2B—brain—multiple sclerosis	0.000223	0.00281	CbGeAlD
Eletriptan—PTGS1—spinal cord—multiple sclerosis	0.000205	0.00259	CbGeAlD
Eletriptan—HTR1A—brain—multiple sclerosis	0.0002	0.00252	CbGeAlD
Eletriptan—HTR7—brain—multiple sclerosis	0.000191	0.00241	CbGeAlD
Eletriptan—ABCB1—retina—multiple sclerosis	0.000188	0.00237	CbGeAlD
Eletriptan—PTGS1—nervous system—multiple sclerosis	0.000173	0.00218	CbGeAlD
Eletriptan—PTGS1—central nervous system—multiple sclerosis	0.000166	0.0021	CbGeAlD
Eletriptan—CYP3A4—nervous system—multiple sclerosis	0.000144	0.00182	CbGeAlD
Eletriptan—CYP2D6—nervous system—multiple sclerosis	0.000142	0.00179	CbGeAlD
Eletriptan—CYP3A4—central nervous system—multiple sclerosis	0.000139	0.00175	CbGeAlD
Eletriptan—CYP2D6—central nervous system—multiple sclerosis	0.000137	0.00172	CbGeAlD
Eletriptan—ABCB1—medulla oblongata—multiple sclerosis	0.000136	0.00171	CbGeAlD
Eletriptan—CYP2D6—cerebellum—multiple sclerosis	0.000133	0.00168	CbGeAlD
Eletriptan—PTGS1—brain—multiple sclerosis	0.000132	0.00166	CbGeAlD
Eletriptan—ABCB1—midbrain—multiple sclerosis	0.000124	0.00157	CbGeAlD
Eletriptan—ABCB1—spinal cord—multiple sclerosis	0.000121	0.00153	CbGeAlD
Eletriptan—CYP2D6—brain—multiple sclerosis	0.000108	0.00137	CbGeAlD
Eletriptan—ABCB1—nervous system—multiple sclerosis	0.000102	0.00129	CbGeAlD
Eletriptan—ABCB1—central nervous system—multiple sclerosis	9.82e-05	0.00124	CbGeAlD
Eletriptan—ABCB1—cerebellum—multiple sclerosis	9.6e-05	0.00121	CbGeAlD
Eletriptan—Angioedema—Betamethasone—multiple sclerosis	8.7e-05	0.000845	CcSEcCtD
Eletriptan—Angioedema—Dexamethasone—multiple sclerosis	8.7e-05	0.000845	CcSEcCtD
Eletriptan—Stomatitis—Methotrexate—multiple sclerosis	8.64e-05	0.000839	CcSEcCtD
Eletriptan—Conjunctivitis—Methotrexate—multiple sclerosis	8.62e-05	0.000837	CcSEcCtD
Eletriptan—Confusional state—Methylprednisolone—multiple sclerosis	8.61e-05	0.000837	CcSEcCtD
Eletriptan—Immune system disorder—Prednisone—multiple sclerosis	8.6e-05	0.000835	CcSEcCtD
Eletriptan—Malaise—Betamethasone—multiple sclerosis	8.58e-05	0.000834	CcSEcCtD
Eletriptan—Malaise—Dexamethasone—multiple sclerosis	8.58e-05	0.000834	CcSEcCtD
Eletriptan—Oedema—Triamcinolone—multiple sclerosis	8.56e-05	0.000832	CcSEcCtD
Eletriptan—Vertigo—Dexamethasone—multiple sclerosis	8.55e-05	0.000831	CcSEcCtD
Eletriptan—Vertigo—Betamethasone—multiple sclerosis	8.55e-05	0.000831	CcSEcCtD
Eletriptan—Syncope—Dexamethasone—multiple sclerosis	8.53e-05	0.000829	CcSEcCtD
Eletriptan—Syncope—Betamethasone—multiple sclerosis	8.53e-05	0.000829	CcSEcCtD
Eletriptan—Arrhythmia—Prednisone—multiple sclerosis	8.51e-05	0.000826	CcSEcCtD
Eletriptan—Sweating—Methotrexate—multiple sclerosis	8.5e-05	0.000825	CcSEcCtD
Eletriptan—Shock—Triamcinolone—multiple sclerosis	8.42e-05	0.000818	CcSEcCtD
Eletriptan—Insomnia—Prednisolone—multiple sclerosis	8.42e-05	0.000818	CcSEcCtD
Eletriptan—Alopecia—Prednisone—multiple sclerosis	8.41e-05	0.000817	CcSEcCtD
Eletriptan—Shock—Methylprednisolone—multiple sclerosis	8.4e-05	0.000816	CcSEcCtD
Eletriptan—Nervous system disorder—Methylprednisolone—multiple sclerosis	8.38e-05	0.000814	CcSEcCtD
Eletriptan—Loss of consciousness—Dexamethasone—multiple sclerosis	8.36e-05	0.000813	CcSEcCtD
Eletriptan—Loss of consciousness—Betamethasone—multiple sclerosis	8.36e-05	0.000813	CcSEcCtD
Eletriptan—Epistaxis—Methotrexate—multiple sclerosis	8.36e-05	0.000812	CcSEcCtD
Eletriptan—Hypersensitivity—Mitoxantrone—multiple sclerosis	8.36e-05	0.000812	CcSEcCtD
Eletriptan—Paraesthesia—Prednisolone—multiple sclerosis	8.36e-05	0.000812	CcSEcCtD
Eletriptan—Tachycardia—Triamcinolone—multiple sclerosis	8.35e-05	0.000812	CcSEcCtD
Eletriptan—Nausea—Azathioprine—multiple sclerosis	8.34e-05	0.00081	CcSEcCtD
Eletriptan—Tachycardia—Methylprednisolone—multiple sclerosis	8.34e-05	0.00081	CcSEcCtD
Eletriptan—Skin disorder—Methylprednisolone—multiple sclerosis	8.3e-05	0.000806	CcSEcCtD
Eletriptan—Hyperhidrosis—Triamcinolone—multiple sclerosis	8.28e-05	0.000804	CcSEcCtD
Eletriptan—Hyperhidrosis—Methylprednisolone—multiple sclerosis	8.26e-05	0.000802	CcSEcCtD
Eletriptan—Convulsion—Dexamethasone—multiple sclerosis	8.25e-05	0.000801	CcSEcCtD
Eletriptan—Convulsion—Betamethasone—multiple sclerosis	8.25e-05	0.000801	CcSEcCtD
Eletriptan—Hypertension—Dexamethasone—multiple sclerosis	8.22e-05	0.000798	CcSEcCtD
Eletriptan—Hypertension—Betamethasone—multiple sclerosis	8.22e-05	0.000798	CcSEcCtD
Eletriptan—Asthenia—Mitoxantrone—multiple sclerosis	8.14e-05	0.000791	CcSEcCtD
Eletriptan—Myalgia—Dexamethasone—multiple sclerosis	8.1e-05	0.000787	CcSEcCtD
Eletriptan—Myalgia—Betamethasone—multiple sclerosis	8.1e-05	0.000787	CcSEcCtD
Eletriptan—Anxiety—Dexamethasone—multiple sclerosis	8.07e-05	0.000784	CcSEcCtD
Eletriptan—Anxiety—Betamethasone—multiple sclerosis	8.07e-05	0.000784	CcSEcCtD
Eletriptan—Discomfort—Betamethasone—multiple sclerosis	8.01e-05	0.000778	CcSEcCtD
Eletriptan—Discomfort—Dexamethasone—multiple sclerosis	8.01e-05	0.000778	CcSEcCtD
Eletriptan—Hypotension—Methylprednisolone—multiple sclerosis	7.98e-05	0.000775	CcSEcCtD
Eletriptan—Pain—Prednisolone—multiple sclerosis	7.96e-05	0.000773	CcSEcCtD
Eletriptan—Pharyngitis—Methotrexate—multiple sclerosis	7.9e-05	0.000767	CcSEcCtD
Eletriptan—Urinary tract disorder—Methotrexate—multiple sclerosis	7.86e-05	0.000763	CcSEcCtD
Eletriptan—Urethral disorder—Methotrexate—multiple sclerosis	7.8e-05	0.000758	CcSEcCtD
Eletriptan—ABCB1—brain—multiple sclerosis	7.8e-05	0.000984	CbGeAlD
Eletriptan—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	7.8e-05	0.000758	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	7.78e-05	0.000756	CcSEcCtD
Eletriptan—Oedema—Betamethasone—multiple sclerosis	7.77e-05	0.000754	CcSEcCtD
Eletriptan—Oedema—Dexamethasone—multiple sclerosis	7.77e-05	0.000754	CcSEcCtD
Eletriptan—Diarrhoea—Mitoxantrone—multiple sclerosis	7.76e-05	0.000754	CcSEcCtD
Eletriptan—Insomnia—Triamcinolone—multiple sclerosis	7.74e-05	0.000752	CcSEcCtD
Eletriptan—Insomnia—Methylprednisolone—multiple sclerosis	7.73e-05	0.00075	CcSEcCtD
Eletriptan—Ill-defined disorder—Prednisone—multiple sclerosis	7.69e-05	0.000747	CcSEcCtD
Eletriptan—Paraesthesia—Triamcinolone—multiple sclerosis	7.69e-05	0.000747	CcSEcCtD
Eletriptan—Feeling abnormal—Prednisolone—multiple sclerosis	7.67e-05	0.000745	CcSEcCtD
Eletriptan—Paraesthesia—Methylprednisolone—multiple sclerosis	7.67e-05	0.000745	CcSEcCtD
Eletriptan—Visual impairment—Methotrexate—multiple sclerosis	7.67e-05	0.000745	CcSEcCtD
Eletriptan—Anaemia—Prednisone—multiple sclerosis	7.66e-05	0.000744	CcSEcCtD
Eletriptan—Shock—Dexamethasone—multiple sclerosis	7.64e-05	0.000742	CcSEcCtD
Eletriptan—Shock—Betamethasone—multiple sclerosis	7.64e-05	0.000742	CcSEcCtD
Eletriptan—Dyspnoea—Triamcinolone—multiple sclerosis	7.63e-05	0.000741	CcSEcCtD
Eletriptan—Nervous system disorder—Betamethasone—multiple sclerosis	7.62e-05	0.00074	CcSEcCtD
Eletriptan—Nervous system disorder—Dexamethasone—multiple sclerosis	7.62e-05	0.00074	CcSEcCtD
Eletriptan—Agitation—Prednisone—multiple sclerosis	7.62e-05	0.00074	CcSEcCtD
Eletriptan—Tachycardia—Betamethasone—multiple sclerosis	7.58e-05	0.000736	CcSEcCtD
Eletriptan—Tachycardia—Dexamethasone—multiple sclerosis	7.58e-05	0.000736	CcSEcCtD
Eletriptan—Angioedema—Prednisone—multiple sclerosis	7.57e-05	0.000736	CcSEcCtD
Eletriptan—Dyspepsia—Triamcinolone—multiple sclerosis	7.54e-05	0.000732	CcSEcCtD
Eletriptan—Dyspepsia—Methylprednisolone—multiple sclerosis	7.52e-05	0.00073	CcSEcCtD
Eletriptan—Hyperhidrosis—Dexamethasone—multiple sclerosis	7.51e-05	0.000729	CcSEcCtD
Eletriptan—Hyperhidrosis—Betamethasone—multiple sclerosis	7.51e-05	0.000729	CcSEcCtD
Eletriptan—Malaise—Prednisone—multiple sclerosis	7.47e-05	0.000726	CcSEcCtD
Eletriptan—Vertigo—Prednisone—multiple sclerosis	7.45e-05	0.000723	CcSEcCtD
Eletriptan—Syncope—Prednisone—multiple sclerosis	7.43e-05	0.000722	CcSEcCtD
Eletriptan—Tinnitus—Methotrexate—multiple sclerosis	7.42e-05	0.000721	CcSEcCtD
Eletriptan—Anorexia—Dexamethasone—multiple sclerosis	7.4e-05	0.000719	CcSEcCtD
Eletriptan—Anorexia—Betamethasone—multiple sclerosis	7.4e-05	0.000719	CcSEcCtD
Eletriptan—Urticaria—Prednisolone—multiple sclerosis	7.4e-05	0.000718	CcSEcCtD
Eletriptan—Fatigue—Triamcinolone—multiple sclerosis	7.38e-05	0.000717	CcSEcCtD
Eletriptan—Fatigue—Methylprednisolone—multiple sclerosis	7.36e-05	0.000715	CcSEcCtD
Eletriptan—Pain—Triamcinolone—multiple sclerosis	7.32e-05	0.000711	CcSEcCtD
Eletriptan—Loss of consciousness—Prednisone—multiple sclerosis	7.28e-05	0.000708	CcSEcCtD
Eletriptan—Hypotension—Betamethasone—multiple sclerosis	7.26e-05	0.000705	CcSEcCtD
Eletriptan—Hypotension—Dexamethasone—multiple sclerosis	7.26e-05	0.000705	CcSEcCtD
Eletriptan—Vomiting—Mitoxantrone—multiple sclerosis	7.21e-05	0.000701	CcSEcCtD
Eletriptan—Immune system disorder—Methotrexate—multiple sclerosis	7.19e-05	0.000698	CcSEcCtD
Eletriptan—Convulsion—Prednisone—multiple sclerosis	7.18e-05	0.000698	CcSEcCtD
Eletriptan—Hypertension—Prednisone—multiple sclerosis	7.16e-05	0.000695	CcSEcCtD
Eletriptan—Rash—Mitoxantrone—multiple sclerosis	7.15e-05	0.000695	CcSEcCtD
Eletriptan—Dermatitis—Mitoxantrone—multiple sclerosis	7.15e-05	0.000694	CcSEcCtD
Eletriptan—Chills—Methotrexate—multiple sclerosis	7.14e-05	0.000693	CcSEcCtD
Eletriptan—Headache—Mitoxantrone—multiple sclerosis	7.11e-05	0.00069	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	7.08e-05	0.000687	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	7.08e-05	0.000687	CcSEcCtD
Eletriptan—Arthralgia—Prednisone—multiple sclerosis	7.06e-05	0.000685	CcSEcCtD
Eletriptan—Myalgia—Prednisone—multiple sclerosis	7.06e-05	0.000685	CcSEcCtD
Eletriptan—Feeling abnormal—Triamcinolone—multiple sclerosis	7.05e-05	0.000685	CcSEcCtD
Eletriptan—Feeling abnormal—Methylprednisolone—multiple sclerosis	7.04e-05	0.000684	CcSEcCtD
Eletriptan—Anxiety—Prednisone—multiple sclerosis	7.03e-05	0.000683	CcSEcCtD
Eletriptan—Alopecia—Methotrexate—multiple sclerosis	7.03e-05	0.000683	CcSEcCtD
Eletriptan—Insomnia—Dexamethasone—multiple sclerosis	7.03e-05	0.000682	CcSEcCtD
Eletriptan—Insomnia—Betamethasone—multiple sclerosis	7.03e-05	0.000682	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	7.01e-05	0.000681	CcSEcCtD
Eletriptan—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	6.98e-05	0.000678	CcSEcCtD
Eletriptan—Paraesthesia—Dexamethasone—multiple sclerosis	6.97e-05	0.000677	CcSEcCtD
Eletriptan—Paraesthesia—Betamethasone—multiple sclerosis	6.97e-05	0.000677	CcSEcCtD
Eletriptan—Discomfort—Prednisone—multiple sclerosis	6.97e-05	0.000677	CcSEcCtD
Eletriptan—Hypersensitivity—Prednisolone—multiple sclerosis	6.86e-05	0.000666	CcSEcCtD
Eletriptan—Dyspepsia—Betamethasone—multiple sclerosis	6.84e-05	0.000664	CcSEcCtD
Eletriptan—Dyspepsia—Dexamethasone—multiple sclerosis	6.84e-05	0.000664	CcSEcCtD
Eletriptan—Urticaria—Triamcinolone—multiple sclerosis	6.8e-05	0.000661	CcSEcCtD
Eletriptan—Urticaria—Methylprednisolone—multiple sclerosis	6.79e-05	0.000659	CcSEcCtD
Eletriptan—Dysgeusia—Methotrexate—multiple sclerosis	6.78e-05	0.000659	CcSEcCtD
Eletriptan—Body temperature increased—Triamcinolone—multiple sclerosis	6.77e-05	0.000657	CcSEcCtD
Eletriptan—Oedema—Prednisone—multiple sclerosis	6.76e-05	0.000657	CcSEcCtD
Eletriptan—Abdominal pain—Methylprednisolone—multiple sclerosis	6.75e-05	0.000656	CcSEcCtD
Eletriptan—Decreased appetite—Dexamethasone—multiple sclerosis	6.75e-05	0.000656	CcSEcCtD
Eletriptan—Decreased appetite—Betamethasone—multiple sclerosis	6.75e-05	0.000656	CcSEcCtD
Eletriptan—Nausea—Mitoxantrone—multiple sclerosis	6.74e-05	0.000655	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	6.71e-05	0.000651	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Betamethasone—multiple sclerosis	6.71e-05	0.000651	CcSEcCtD
Eletriptan—Back pain—Methotrexate—multiple sclerosis	6.7e-05	0.000651	CcSEcCtD
Eletriptan—Fatigue—Dexamethasone—multiple sclerosis	6.7e-05	0.00065	CcSEcCtD
Eletriptan—Fatigue—Betamethasone—multiple sclerosis	6.7e-05	0.00065	CcSEcCtD
Eletriptan—Shock—Prednisone—multiple sclerosis	6.66e-05	0.000646	CcSEcCtD
Eletriptan—Pain—Dexamethasone—multiple sclerosis	6.64e-05	0.000645	CcSEcCtD
Eletriptan—Pain—Betamethasone—multiple sclerosis	6.64e-05	0.000645	CcSEcCtD
Eletriptan—Nervous system disorder—Prednisone—multiple sclerosis	6.63e-05	0.000644	CcSEcCtD
Eletriptan—Tachycardia—Prednisone—multiple sclerosis	6.6e-05	0.000641	CcSEcCtD
Eletriptan—Skin disorder—Prednisone—multiple sclerosis	6.57e-05	0.000638	CcSEcCtD
Eletriptan—Hyperhidrosis—Prednisone—multiple sclerosis	6.54e-05	0.000635	CcSEcCtD
Eletriptan—Anorexia—Prednisone—multiple sclerosis	6.45e-05	0.000626	CcSEcCtD
Eletriptan—Ill-defined disorder—Methotrexate—multiple sclerosis	6.43e-05	0.000624	CcSEcCtD
Eletriptan—Anaemia—Methotrexate—multiple sclerosis	6.4e-05	0.000622	CcSEcCtD
Eletriptan—Feeling abnormal—Dexamethasone—multiple sclerosis	6.4e-05	0.000622	CcSEcCtD
Eletriptan—Feeling abnormal—Betamethasone—multiple sclerosis	6.4e-05	0.000622	CcSEcCtD
Eletriptan—Gastrointestinal pain—Dexamethasone—multiple sclerosis	6.35e-05	0.000617	CcSEcCtD
Eletriptan—Gastrointestinal pain—Betamethasone—multiple sclerosis	6.35e-05	0.000617	CcSEcCtD
Eletriptan—Hypersensitivity—Triamcinolone—multiple sclerosis	6.31e-05	0.000613	CcSEcCtD
Eletriptan—Hypersensitivity—Methylprednisolone—multiple sclerosis	6.29e-05	0.000611	CcSEcCtD
Eletriptan—Malaise—Methotrexate—multiple sclerosis	6.25e-05	0.000607	CcSEcCtD
Eletriptan—Vertigo—Methotrexate—multiple sclerosis	6.22e-05	0.000604	CcSEcCtD
Eletriptan—Leukopenia—Methotrexate—multiple sclerosis	6.2e-05	0.000602	CcSEcCtD
Eletriptan—Urticaria—Dexamethasone—multiple sclerosis	6.17e-05	0.000599	CcSEcCtD
Eletriptan—Urticaria—Betamethasone—multiple sclerosis	6.17e-05	0.000599	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Prednisone—multiple sclerosis	6.16e-05	0.000599	CcSEcCtD
Eletriptan—Dizziness—Prednisolone—multiple sclerosis	6.16e-05	0.000598	CcSEcCtD
Eletriptan—Asthenia—Triamcinolone—multiple sclerosis	6.14e-05	0.000597	CcSEcCtD
Eletriptan—Body temperature increased—Dexamethasone—multiple sclerosis	6.14e-05	0.000596	CcSEcCtD
Eletriptan—Abdominal pain—Betamethasone—multiple sclerosis	6.14e-05	0.000596	CcSEcCtD
Eletriptan—Abdominal pain—Dexamethasone—multiple sclerosis	6.14e-05	0.000596	CcSEcCtD
Eletriptan—Body temperature increased—Betamethasone—multiple sclerosis	6.14e-05	0.000596	CcSEcCtD
Eletriptan—Asthenia—Methylprednisolone—multiple sclerosis	6.13e-05	0.000595	CcSEcCtD
Eletriptan—Insomnia—Prednisone—multiple sclerosis	6.12e-05	0.000594	CcSEcCtD
Eletriptan—Paraesthesia—Prednisone—multiple sclerosis	6.07e-05	0.00059	CcSEcCtD
Eletriptan—Pruritus—Triamcinolone—multiple sclerosis	6.06e-05	0.000588	CcSEcCtD
Eletriptan—Cough—Methotrexate—multiple sclerosis	6.04e-05	0.000587	CcSEcCtD
Eletriptan—Pruritus—Methylprednisolone—multiple sclerosis	6.04e-05	0.000587	CcSEcCtD
Eletriptan—Convulsion—Methotrexate—multiple sclerosis	6e-05	0.000583	CcSEcCtD
Eletriptan—Dyspepsia—Prednisone—multiple sclerosis	5.95e-05	0.000578	CcSEcCtD
Eletriptan—Arthralgia—Methotrexate—multiple sclerosis	5.9e-05	0.000573	CcSEcCtD
Eletriptan—Myalgia—Methotrexate—multiple sclerosis	5.9e-05	0.000573	CcSEcCtD
Eletriptan—Decreased appetite—Prednisone—multiple sclerosis	5.88e-05	0.000571	CcSEcCtD
Eletriptan—Rash—Prednisolone—multiple sclerosis	5.87e-05	0.00057	CcSEcCtD
Eletriptan—Dermatitis—Prednisolone—multiple sclerosis	5.86e-05	0.00057	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	5.86e-05	0.000569	CcSEcCtD
Eletriptan—Diarrhoea—Methylprednisolone—multiple sclerosis	5.84e-05	0.000568	CcSEcCtD
Eletriptan—Fatigue—Prednisone—multiple sclerosis	5.83e-05	0.000566	CcSEcCtD
Eletriptan—Headache—Prednisolone—multiple sclerosis	5.83e-05	0.000566	CcSEcCtD
Eletriptan—Discomfort—Methotrexate—multiple sclerosis	5.83e-05	0.000566	CcSEcCtD
Eletriptan—Constipation—Prednisone—multiple sclerosis	5.78e-05	0.000562	CcSEcCtD
Eletriptan—Confusional state—Methotrexate—multiple sclerosis	5.7e-05	0.000554	CcSEcCtD
Eletriptan—Dizziness—Triamcinolone—multiple sclerosis	5.66e-05	0.00055	CcSEcCtD
Eletriptan—Dizziness—Methylprednisolone—multiple sclerosis	5.65e-05	0.000549	CcSEcCtD
Eletriptan—Feeling abnormal—Prednisone—multiple sclerosis	5.57e-05	0.000541	CcSEcCtD
Eletriptan—Asthenia—Dexamethasone—multiple sclerosis	5.57e-05	0.000541	CcSEcCtD
Eletriptan—Asthenia—Betamethasone—multiple sclerosis	5.57e-05	0.000541	CcSEcCtD
Eletriptan—Nervous system disorder—Methotrexate—multiple sclerosis	5.54e-05	0.000538	CcSEcCtD
Eletriptan—Gastrointestinal pain—Prednisone—multiple sclerosis	5.53e-05	0.000537	CcSEcCtD
Eletriptan—Nausea—Prednisolone—multiple sclerosis	5.53e-05	0.000537	CcSEcCtD
Eletriptan—Pruritus—Dexamethasone—multiple sclerosis	5.5e-05	0.000534	CcSEcCtD
Eletriptan—Pruritus—Betamethasone—multiple sclerosis	5.5e-05	0.000534	CcSEcCtD
Eletriptan—Skin disorder—Methotrexate—multiple sclerosis	5.49e-05	0.000533	CcSEcCtD
Eletriptan—Hyperhidrosis—Methotrexate—multiple sclerosis	5.47e-05	0.000531	CcSEcCtD
Eletriptan—Vomiting—Triamcinolone—multiple sclerosis	5.44e-05	0.000529	CcSEcCtD
Eletriptan—Vomiting—Methylprednisolone—multiple sclerosis	5.43e-05	0.000528	CcSEcCtD
Eletriptan—Rash—Triamcinolone—multiple sclerosis	5.4e-05	0.000524	CcSEcCtD
Eletriptan—Dermatitis—Triamcinolone—multiple sclerosis	5.39e-05	0.000524	CcSEcCtD
Eletriptan—Anorexia—Methotrexate—multiple sclerosis	5.39e-05	0.000523	CcSEcCtD
Eletriptan—Rash—Methylprednisolone—multiple sclerosis	5.39e-05	0.000523	CcSEcCtD
Eletriptan—Dermatitis—Methylprednisolone—multiple sclerosis	5.38e-05	0.000523	CcSEcCtD
Eletriptan—Urticaria—Prednisone—multiple sclerosis	5.37e-05	0.000522	CcSEcCtD
Eletriptan—Headache—Triamcinolone—multiple sclerosis	5.36e-05	0.000521	CcSEcCtD
Eletriptan—Headache—Methylprednisolone—multiple sclerosis	5.35e-05	0.00052	CcSEcCtD
Eletriptan—Body temperature increased—Prednisone—multiple sclerosis	5.35e-05	0.000519	CcSEcCtD
Eletriptan—Abdominal pain—Prednisone—multiple sclerosis	5.35e-05	0.000519	CcSEcCtD
Eletriptan—Diarrhoea—Betamethasone—multiple sclerosis	5.31e-05	0.000516	CcSEcCtD
Eletriptan—Diarrhoea—Dexamethasone—multiple sclerosis	5.31e-05	0.000516	CcSEcCtD
Eletriptan—Hypotension—Methotrexate—multiple sclerosis	5.28e-05	0.000513	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	5.15e-05	0.0005	CcSEcCtD
Eletriptan—Dizziness—Betamethasone—multiple sclerosis	5.14e-05	0.000499	CcSEcCtD
Eletriptan—Dizziness—Dexamethasone—multiple sclerosis	5.14e-05	0.000499	CcSEcCtD
Eletriptan—Insomnia—Methotrexate—multiple sclerosis	5.11e-05	0.000497	CcSEcCtD
Eletriptan—Nausea—Triamcinolone—multiple sclerosis	5.08e-05	0.000494	CcSEcCtD
Eletriptan—Paraesthesia—Methotrexate—multiple sclerosis	5.08e-05	0.000493	CcSEcCtD
Eletriptan—Nausea—Methylprednisolone—multiple sclerosis	5.07e-05	0.000493	CcSEcCtD
Eletriptan—Dyspnoea—Methotrexate—multiple sclerosis	5.04e-05	0.00049	CcSEcCtD
Eletriptan—Somnolence—Methotrexate—multiple sclerosis	5.03e-05	0.000488	CcSEcCtD
Eletriptan—Hypersensitivity—Prednisone—multiple sclerosis	4.98e-05	0.000484	CcSEcCtD
Eletriptan—Dyspepsia—Methotrexate—multiple sclerosis	4.98e-05	0.000483	CcSEcCtD
Eletriptan—Vomiting—Betamethasone—multiple sclerosis	4.94e-05	0.00048	CcSEcCtD
Eletriptan—Vomiting—Dexamethasone—multiple sclerosis	4.94e-05	0.00048	CcSEcCtD
Eletriptan—Decreased appetite—Methotrexate—multiple sclerosis	4.91e-05	0.000477	CcSEcCtD
Eletriptan—Rash—Dexamethasone—multiple sclerosis	4.9e-05	0.000476	CcSEcCtD
Eletriptan—Rash—Betamethasone—multiple sclerosis	4.9e-05	0.000476	CcSEcCtD
Eletriptan—Dermatitis—Betamethasone—multiple sclerosis	4.89e-05	0.000475	CcSEcCtD
Eletriptan—Dermatitis—Dexamethasone—multiple sclerosis	4.89e-05	0.000475	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Methotrexate—multiple sclerosis	4.88e-05	0.000474	CcSEcCtD
Eletriptan—Fatigue—Methotrexate—multiple sclerosis	4.87e-05	0.000473	CcSEcCtD
Eletriptan—Headache—Dexamethasone—multiple sclerosis	4.87e-05	0.000473	CcSEcCtD
Eletriptan—Headache—Betamethasone—multiple sclerosis	4.87e-05	0.000473	CcSEcCtD
Eletriptan—Asthenia—Prednisone—multiple sclerosis	4.85e-05	0.000471	CcSEcCtD
Eletriptan—Pain—Methotrexate—multiple sclerosis	4.83e-05	0.00047	CcSEcCtD
Eletriptan—Pruritus—Prednisone—multiple sclerosis	4.79e-05	0.000465	CcSEcCtD
Eletriptan—Feeling abnormal—Methotrexate—multiple sclerosis	4.66e-05	0.000452	CcSEcCtD
Eletriptan—Diarrhoea—Prednisone—multiple sclerosis	4.63e-05	0.00045	CcSEcCtD
Eletriptan—Gastrointestinal pain—Methotrexate—multiple sclerosis	4.62e-05	0.000449	CcSEcCtD
Eletriptan—Nausea—Dexamethasone—multiple sclerosis	4.61e-05	0.000448	CcSEcCtD
Eletriptan—Nausea—Betamethasone—multiple sclerosis	4.61e-05	0.000448	CcSEcCtD
Eletriptan—Urticaria—Methotrexate—multiple sclerosis	4.49e-05	0.000436	CcSEcCtD
Eletriptan—Dizziness—Prednisone—multiple sclerosis	4.47e-05	0.000434	CcSEcCtD
Eletriptan—Abdominal pain—Methotrexate—multiple sclerosis	4.47e-05	0.000434	CcSEcCtD
Eletriptan—Body temperature increased—Methotrexate—multiple sclerosis	4.47e-05	0.000434	CcSEcCtD
Eletriptan—Vomiting—Prednisone—multiple sclerosis	4.3e-05	0.000418	CcSEcCtD
Eletriptan—Rash—Prednisone—multiple sclerosis	4.27e-05	0.000414	CcSEcCtD
Eletriptan—Dermatitis—Prednisone—multiple sclerosis	4.26e-05	0.000414	CcSEcCtD
Eletriptan—Headache—Prednisone—multiple sclerosis	4.24e-05	0.000412	CcSEcCtD
Eletriptan—Hypersensitivity—Methotrexate—multiple sclerosis	4.17e-05	0.000405	CcSEcCtD
Eletriptan—Asthenia—Methotrexate—multiple sclerosis	4.06e-05	0.000394	CcSEcCtD
Eletriptan—Nausea—Prednisone—multiple sclerosis	4.02e-05	0.00039	CcSEcCtD
Eletriptan—Pruritus—Methotrexate—multiple sclerosis	4e-05	0.000388	CcSEcCtD
Eletriptan—Diarrhoea—Methotrexate—multiple sclerosis	3.87e-05	0.000376	CcSEcCtD
Eletriptan—Dizziness—Methotrexate—multiple sclerosis	3.74e-05	0.000363	CcSEcCtD
Eletriptan—Vomiting—Methotrexate—multiple sclerosis	3.59e-05	0.000349	CcSEcCtD
Eletriptan—Rash—Methotrexate—multiple sclerosis	3.56e-05	0.000346	CcSEcCtD
Eletriptan—Dermatitis—Methotrexate—multiple sclerosis	3.56e-05	0.000346	CcSEcCtD
Eletriptan—Headache—Methotrexate—multiple sclerosis	3.54e-05	0.000344	CcSEcCtD
Eletriptan—Nausea—Methotrexate—multiple sclerosis	3.36e-05	0.000326	CcSEcCtD
Eletriptan—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.36e-05	0.00027	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CCR5—multiple sclerosis	1.35e-05	0.000269	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CXCR3—multiple sclerosis	1.35e-05	0.000268	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CCR2—multiple sclerosis	1.35e-05	0.000268	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—CCR5—multiple sclerosis	1.34e-05	0.000267	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CCR2—multiple sclerosis	1.34e-05	0.000266	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CD28—multiple sclerosis	1.34e-05	0.000266	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—CCL5—multiple sclerosis	1.33e-05	0.000265	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IL2RA—multiple sclerosis	1.33e-05	0.000265	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GPC5—multiple sclerosis	1.33e-05	0.000265	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.33e-05	0.000264	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—IL2RA—multiple sclerosis	1.32e-05	0.000264	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—IL2—multiple sclerosis	1.32e-05	0.000263	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CCR2—multiple sclerosis	1.31e-05	0.000261	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PTGER4—multiple sclerosis	1.31e-05	0.000261	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—SPP1—multiple sclerosis	1.31e-05	0.00026	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.3e-05	0.00026	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PGR—multiple sclerosis	1.29e-05	0.000257	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CCR5—multiple sclerosis	1.27e-05	0.000253	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—SRM—multiple sclerosis	1.27e-05	0.000253	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CXCR3—multiple sclerosis	1.27e-05	0.000252	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—POMC—multiple sclerosis	1.27e-05	0.000252	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—POMC—multiple sclerosis	1.26e-05	0.00025	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IL2RA—multiple sclerosis	1.25e-05	0.00025	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CD28—multiple sclerosis	1.25e-05	0.00025	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.25e-05	0.000249	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—IL2—multiple sclerosis	1.25e-05	0.000248	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CNR1—multiple sclerosis	1.24e-05	0.000248	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.24e-05	0.000247	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CNR1—multiple sclerosis	1.24e-05	0.000246	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CCR2—multiple sclerosis	1.23e-05	0.000245	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—POMC—multiple sclerosis	1.23e-05	0.000245	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—APOE—multiple sclerosis	1.23e-05	0.000244	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CNR1—multiple sclerosis	1.21e-05	0.000241	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—CCL5—multiple sclerosis	1.21e-05	0.000241	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—CCR5—multiple sclerosis	1.2e-05	0.000239	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.19e-05	0.000237	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—IL2RA—multiple sclerosis	1.18e-05	0.000235	CbGpPWpGaD
Eletriptan—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.18e-05	0.000234	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—APOE—multiple sclerosis	1.16e-05	0.00023	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—POMC—multiple sclerosis	1.16e-05	0.00023	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—POMC—multiple sclerosis	1.15e-05	0.000229	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—POMC—multiple sclerosis	1.14e-05	0.000227	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CNR1—multiple sclerosis	1.14e-05	0.000226	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.13e-05	0.000225	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—CCL2—multiple sclerosis	1.12e-05	0.000224	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—BCHE—multiple sclerosis	1.12e-05	0.000224	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CXCL10—multiple sclerosis	1.12e-05	0.000223	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—POMC—multiple sclerosis	1.12e-05	0.000222	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—CCL2—multiple sclerosis	1.12e-05	0.000222	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CXCL10—multiple sclerosis	1.11e-05	0.000221	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CD80—multiple sclerosis	1.11e-05	0.000221	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CCL3—multiple sclerosis	1.1e-05	0.00022	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—RRM1—multiple sclerosis	1.1e-05	0.000219	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—CCL2—multiple sclerosis	1.09e-05	0.000218	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—CCR5—multiple sclerosis	1.09e-05	0.000217	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CXCL10—multiple sclerosis	1.09e-05	0.000217	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—IL2RA—multiple sclerosis	1.07e-05	0.000214	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PTGER4—multiple sclerosis	1.06e-05	0.000212	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—BCHE—multiple sclerosis	1.06e-05	0.000212	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—POMC—multiple sclerosis	1.05e-05	0.00021	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—POMC—multiple sclerosis	1.05e-05	0.000209	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PGR—multiple sclerosis	1.05e-05	0.000208	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CD80—multiple sclerosis	1.05e-05	0.000208	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.04e-05	0.000207	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CCL2—multiple sclerosis	1.03e-05	0.000205	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.03e-05	0.000205	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—CCL2—multiple sclerosis	1.03e-05	0.000204	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CXCR3—multiple sclerosis	1.03e-05	0.000204	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CXCL10—multiple sclerosis	1.02e-05	0.000204	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—TYK2—multiple sclerosis	1.02e-05	0.000203	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CD28—multiple sclerosis	1.02e-05	0.000202	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.02e-05	0.000202	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—TYK2—multiple sclerosis	1.01e-05	0.000202	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.01e-05	0.000202	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—MAPK1—multiple sclerosis	1.01e-05	0.000201	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CCR2—multiple sclerosis	9.99e-06	0.000199	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—POMC—multiple sclerosis	9.95e-06	0.000198	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	9.94e-06	0.000198	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—TYK2—multiple sclerosis	9.93e-06	0.000198	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CD86—multiple sclerosis	9.79e-06	0.000195	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CCL2—multiple sclerosis	9.73e-06	0.000194	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CD86—multiple sclerosis	9.73e-06	0.000194	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CCL5—multiple sclerosis	9.64e-06	0.000192	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CCL5—multiple sclerosis	9.58e-06	0.000191	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CD86—multiple sclerosis	9.53e-06	0.00019	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—MAPK1—multiple sclerosis	9.52e-06	0.00019	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	9.47e-06	0.000188	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CCL5—multiple sclerosis	9.38e-06	0.000187	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—POMC—multiple sclerosis	9.38e-06	0.000187	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TYK2—multiple sclerosis	9.37e-06	0.000186	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—IL2—multiple sclerosis	9.36e-06	0.000186	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—TYK2—multiple sclerosis	9.33e-06	0.000186	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—IL2—multiple sclerosis	9.29e-06	0.000185	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CNR1—multiple sclerosis	9.22e-06	0.000183	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—IL2—multiple sclerosis	9.1e-06	0.000181	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	8.96e-06	0.000178	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	8.96e-06	0.000178	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CD86—multiple sclerosis	8.95e-06	0.000178	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—SPP1—multiple sclerosis	8.93e-06	0.000178	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—SPP1—multiple sclerosis	8.87e-06	0.000177	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TYK2—multiple sclerosis	8.84e-06	0.000176	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CCL5—multiple sclerosis	8.81e-06	0.000175	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.76e-06	0.000174	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—SPP1—multiple sclerosis	8.69e-06	0.000173	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CCR5—multiple sclerosis	8.69e-06	0.000173	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CCR5—multiple sclerosis	8.63e-06	0.000172	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IL2RA—multiple sclerosis	8.56e-06	0.00017	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—IL2—multiple sclerosis	8.55e-06	0.00017	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—POMC—multiple sclerosis	8.52e-06	0.000169	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IL2RA—multiple sclerosis	8.51e-06	0.000169	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—IL2—multiple sclerosis	8.5e-06	0.000169	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CCR5—multiple sclerosis	8.45e-06	0.000168	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—IL2—multiple sclerosis	8.44e-06	0.000168	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—CCL2—multiple sclerosis	8.33e-06	0.000166	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IL2RA—multiple sclerosis	8.33e-06	0.000166	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CXCL10—multiple sclerosis	8.3e-06	0.000165	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—IL2—multiple sclerosis	8.26e-06	0.000164	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GPC5—multiple sclerosis	8.19e-06	0.000163	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—SPP1—multiple sclerosis	8.16e-06	0.000162	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.98e-06	0.000159	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CCR5—multiple sclerosis	7.94e-06	0.000158	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—APOE—multiple sclerosis	7.9e-06	0.000157	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—APOE—multiple sclerosis	7.85e-06	0.000156	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IL2RA—multiple sclerosis	7.82e-06	0.000156	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IL2—multiple sclerosis	7.8e-06	0.000155	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—IL2—multiple sclerosis	7.76e-06	0.000154	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—IL6—multiple sclerosis	7.76e-06	0.000154	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—APOE—multiple sclerosis	7.69e-06	0.000153	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—TYK2—multiple sclerosis	7.57e-06	0.000151	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.52e-06	0.00015	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—MMP9—multiple sclerosis	7.38e-06	0.000147	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IL2—multiple sclerosis	7.36e-06	0.000146	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—IL6—multiple sclerosis	7.32e-06	0.000146	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CD86—multiple sclerosis	7.26e-06	0.000144	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—APOE—multiple sclerosis	7.22e-06	0.000144	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CCL5—multiple sclerosis	7.15e-06	0.000142	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CD80—multiple sclerosis	7.15e-06	0.000142	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CD80—multiple sclerosis	7.1e-06	0.000141	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—MMP9—multiple sclerosis	6.96e-06	0.000139	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CD80—multiple sclerosis	6.95e-06	0.000138	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—IL2—multiple sclerosis	6.93e-06	0.000138	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.86e-06	0.000136	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.86e-06	0.000136	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—POMC—multiple sclerosis	6.79e-06	0.000135	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—RRM1—multiple sclerosis	6.79e-06	0.000135	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—APOE—multiple sclerosis	6.76e-06	0.000135	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—POMC—multiple sclerosis	6.74e-06	0.000134	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CCL2—multiple sclerosis	6.64e-06	0.000132	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SPP1—multiple sclerosis	6.62e-06	0.000132	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—POMC—multiple sclerosis	6.6e-06	0.000131	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CCL2—multiple sclerosis	6.6e-06	0.000131	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—STAT3—multiple sclerosis	6.56e-06	0.000131	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CD80—multiple sclerosis	6.53e-06	0.00013	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—MAPK1—multiple sclerosis	6.5e-06	0.000129	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—BCHE—multiple sclerosis	6.48e-06	0.000129	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CCL2—multiple sclerosis	6.46e-06	0.000129	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—MAPK1—multiple sclerosis	6.46e-06	0.000128	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CCR5—multiple sclerosis	6.44e-06	0.000128	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—APOE—multiple sclerosis	6.4e-06	0.000127	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.37e-06	0.000127	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL2RA—multiple sclerosis	6.34e-06	0.000126	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—BCHE—multiple sclerosis	6.33e-06	0.000126	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—MAPK1—multiple sclerosis	6.32e-06	0.000126	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—IL2—multiple sclerosis	6.3e-06	0.000125	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.25e-06	0.000124	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—POMC—multiple sclerosis	6.2e-06	0.000123	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—STAT3—multiple sclerosis	6.19e-06	0.000123	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—MYC—multiple sclerosis	6.1e-06	0.000121	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TGFB1—multiple sclerosis	6.08e-06	0.000121	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CCL2—multiple sclerosis	6.07e-06	0.000121	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TYK2—multiple sclerosis	6.03e-06	0.00012	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TYK2—multiple sclerosis	5.99e-06	0.000119	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—MAPK1—multiple sclerosis	5.96e-06	0.000119	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—BCHE—multiple sclerosis	5.96e-06	0.000119	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—MAPK1—multiple sclerosis	5.94e-06	0.000118	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—BCHE—multiple sclerosis	5.91e-06	0.000118	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TYK2—multiple sclerosis	5.87e-06	0.000117	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—APOE—multiple sclerosis	5.86e-06	0.000117	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—POMC—multiple sclerosis	5.81e-06	0.000116	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—MYC—multiple sclerosis	5.75e-06	0.000114	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TGFB1—multiple sclerosis	5.74e-06	0.000114	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—MAPK1—multiple sclerosis	5.63e-06	0.000112	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TYK2—multiple sclerosis	5.51e-06	0.00011	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—POMC—multiple sclerosis	5.49e-06	0.000109	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—ALB—multiple sclerosis	5.3e-06	0.000105	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CD80—multiple sclerosis	5.29e-06	0.000105	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—POMC—multiple sclerosis	5.03e-06	0.0001	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IL2—multiple sclerosis	5.02e-06	9.99e-05	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—ALB—multiple sclerosis	5.01e-06	9.97e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—IL6—multiple sclerosis	4.99e-06	9.94e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IL2—multiple sclerosis	4.99e-06	9.92e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—IL6—multiple sclerosis	4.96e-06	9.87e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	4.92e-06	9.79e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IL2—multiple sclerosis	4.88e-06	9.71e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—IL6—multiple sclerosis	4.86e-06	9.67e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	4.82e-06	9.58e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MMP9—multiple sclerosis	4.75e-06	9.45e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MMP9—multiple sclerosis	4.72e-06	9.39e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MMP9—multiple sclerosis	4.62e-06	9.19e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IL2—multiple sclerosis	4.59e-06	9.13e-05	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IL6—multiple sclerosis	4.58e-06	9.12e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—IL6—multiple sclerosis	4.56e-06	9.08e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	4.47e-06	8.89e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MMP9—multiple sclerosis	4.34e-06	8.64e-05	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IL6—multiple sclerosis	4.32e-06	8.6e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—STAT3—multiple sclerosis	4.22e-06	8.4e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—STAT3—multiple sclerosis	4.2e-06	8.35e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—STAT3—multiple sclerosis	4.11e-06	8.17e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MYC—multiple sclerosis	3.92e-06	7.81e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TGFB1—multiple sclerosis	3.91e-06	7.79e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—APOE—multiple sclerosis	3.9e-06	7.76e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MYC—multiple sclerosis	3.9e-06	7.76e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—BCHE—multiple sclerosis	3.9e-06	7.76e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TGFB1—multiple sclerosis	3.89e-06	7.74e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—STAT3—multiple sclerosis	3.86e-06	7.68e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MAPK1—multiple sclerosis	3.84e-06	7.64e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MYC—multiple sclerosis	3.82e-06	7.6e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MAPK1—multiple sclerosis	3.81e-06	7.59e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TGFB1—multiple sclerosis	3.81e-06	7.58e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—APOE—multiple sclerosis	3.81e-06	7.57e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MAPK1—multiple sclerosis	3.73e-06	7.43e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL2—multiple sclerosis	3.72e-06	7.4e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	3.7e-06	7.36e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—APOE—multiple sclerosis	3.59e-06	7.14e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MYC—multiple sclerosis	3.59e-06	7.14e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TGFB1—multiple sclerosis	3.58e-06	7.12e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—APOE—multiple sclerosis	3.56e-06	7.08e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	3.52e-06	7e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MAPK1—multiple sclerosis	3.51e-06	6.98e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—POMC—multiple sclerosis	3.35e-06	6.67e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—POMC—multiple sclerosis	3.27e-06	6.51e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	3.13e-06	6.23e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—POMC—multiple sclerosis	3.08e-06	6.13e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—POMC—multiple sclerosis	3.05e-06	6.08e-05	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ALB—multiple sclerosis	3.05e-06	6.08e-05	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ALB—multiple sclerosis	2.98e-06	5.93e-05	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IL6—multiple sclerosis	2.95e-06	5.87e-05	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IL6—multiple sclerosis	2.93e-06	5.83e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MYC—multiple sclerosis	2.91e-06	5.79e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	2.9e-06	5.77e-05	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IL6—multiple sclerosis	2.87e-06	5.71e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	2.85e-06	5.66e-05	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ALB—multiple sclerosis	2.81e-06	5.59e-05	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ALB—multiple sclerosis	2.79e-06	5.54e-05	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IL6—multiple sclerosis	2.7e-06	5.36e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—APOE—multiple sclerosis	2.35e-06	4.67e-05	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL6—multiple sclerosis	2.19e-06	4.35e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—POMC—multiple sclerosis	2.01e-06	4.01e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ALB—multiple sclerosis	1.84e-06	3.65e-05	CbGpPWpGaD
